News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER builds on current knowledge about symptoms affecting the lungs and heart
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.
Feature
166 Results
166 Results
Representatives identify community needs to improve support for people with Long COVID
The co-chairs of RECOVER’s National Community Engagement Group conducted listening sessions with 24 Community Representatives and detailed key themes in a new report.
Feature
Participant advisory group at RECOVER hub raises awareness about Long COVID
The ILLInet PARATROOPers, a a group of RECOVER study participants, collaborate with researchers to center the voices of Long COVID patients, improve RECOVER studies, and raise awareness about the condition.
Feature
R3 Seminar Recap: Impact of Long COVID on neurocognitive function
At the RECOVER Research Review (R3) Seminar held on April 14, RECOVER researchers presented findings on how Long COVID affects the brain, including difficulties with thinking clearly, memory, and concentration. They also outlined future research opportunities to better understand neurocognitive symptoms and how other body systems impact brain health.
R3 Seminar Recap
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
RECOVER continues to focus on understanding symptoms that affect the brain
RECOVER researchers are continuing plans to explore cognitive symptoms like brain fog in the initiative’s adult observational study, one of the most common but least understood symptoms of Long COVID.
Feature
RECOVER-AUTONOMIC clinical trial results shared at 2026 ACC Conference
The RECOVER-AUTONOMIC (Ivabradine) clinical trial tested whether ivabradine, an oral medication used to lower heart rate, could be used to manage a Long COVID symptom called postural orthostatic tachycardia syndrome (POTS).
Announcement
Honoring the many lived experiences with Long COVID
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Feature
RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will share insights and answer questions about the progress being made on the first wave of RECOVER-TLC clinical trials.
Announcement